<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02505555</url>
  </required_header>
  <id_info>
    <org_study_id>PekingUFH-4DF</org_study_id>
    <secondary_id>4D-HyCoSy</secondary_id>
    <nct_id>NCT02505555</nct_id>
  </id_info>
  <brief_title>Feasibility of Four-dimensional Hysterosalpingo-contrast Sonography With SonoVue for Assessment of Tubal Patency</brief_title>
  <official_title>Accuracy and Tolerability of Four-dimensional Hysterosalpingo-contrast Sonography With SonoVue for Assessment of Tubal Patency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University First Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University First Hospital</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to summarize our experience with and to evaluate the feasibility
      of transvaginal four-dimensional hysterosalpingo-contrast sonography using SonoVue
      (4D-HyCoSy) for assessment of fallopian tubal patency, women attending the fertility clinic
      are recruited. All of the patients are tried to be examined with 4D-HyCoSy,some of who
      undergone laparoscopy and dye. Then the results of 4D-HyCoSy and lap and dye are compared.
      All of the patients will be followed up. The complications of 4D-HyCoSy will be evaluated and
      the pregnancy outcomes will be recorded.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2013</start_date>
  <primary_completion_date type="Anticipated">February 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity and specificity of four-dimensional hysterosalpingo-contrast sonography with SonoVue</measure>
    <time_frame>at least one year</time_frame>
    <description>Sensitivity, specificity, accuracy, positive predictive value, negative predictive value</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>side effects and complications of four-dimensional hysterosalpingo-contrast sonography</measure>
    <time_frame>at least one year</time_frame>
    <description>the intensity of pain perception, vaginal bleeding, fever, pelvic inflammatory diseases，peritonitis，and the pregnancy outcomes</description>
  </secondary_outcome>
  <enrollment type="Anticipated">380</enrollment>
  <condition>Four Dimensional Hysterosalpingo-contrast Sonography</condition>
  <condition>Tubal Patency</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>four dimensional hysterosalpingo-contrast sonography</intervention_name>
    <description>compare accuracy and tolerability of 4D-HyCoSy with that of laparoscopy and chromotubation</description>
    <other_name>4D-HyCoSy</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women who have infertility and try to evaluate tubal patency by 4D-HyCoSy in our hospital
        will be recruited.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women who have infertility and need to evaluate tubal patency.

        Exclusion Criteria:

          1. vaginal bleeding;

          2. acute or subacute inflammation of the reproductive system;

          3. uterine malignancies;

          4. allergies to the medications used in the examination, such as lidocaine, atropine, and
             sulfur hexafluoride
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Wen pei Bai, M.D.</last_name>
    <phone>+86 133-6615-7805</phone>
    <phone_ext>10 8357 221</phone_ext>
    <email>bwp66@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Peking University First Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100034</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wen Pei Bai, M.D.</last_name>
      <phone>+86 133-6615-7805</phone>
      <phone_ext>10 8357 2211</phone_ext>
      <email>bwp66@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/?term=Marana%2C+R.%2C+et+al.%2C+%5BRole+of+a+mini-invasive+approach+in+the+diagnosis+and+treatment+of+tubo-peritoneal+infertility+as+an+altenative+to+IVF%5D.+Minerva+Ginecol%2C+2011.+63(1)%3A+p.+1-10.</url>
  </link>
  <results_reference>
    <citation>Marana R, Ferrari S, Merola A, Astorri AL, Pompa G, Milardi D, Giampietro A, Lecca A, Marana E. [Role of a mini-invasive approach in the diagnosis and treatment of tubo-peritoneal infertility as an altenative to IVF]. Minerva Ginecol. 2011 Feb;63(1):1-10. Italian.</citation>
    <PMID>21311415</PMID>
  </results_reference>
  <results_reference>
    <citation>Luciano DE, Exacoustos C, Luciano AA. Contrast ultrasonography for tubal patency. J Minim Invasive Gynecol. 2014 Nov-Dec;21(6):994-8. doi: 10.1016/j.jmig.2014.05.017. Epub 2014 Jun 6. Review.</citation>
    <PMID>24910933</PMID>
  </results_reference>
  <results_reference>
    <citation>Maheux-Lacroix S, Boutin A, Moore L, Bergeron ME, Bujold E, Laberge P, Lemyre M, Dodin S. Hysterosalpingosonography for diagnosing tubal occlusion in subfertile women: a systematic review with meta-analysis. Hum Reprod. 2014 May;29(5):953-63. doi: 10.1093/humrep/deu024. Epub 2014 Feb 26. Review.</citation>
    <PMID>24578476</PMID>
  </results_reference>
  <results_reference>
    <citation>Exacoustos C, Di Giovanni A, Szabolcs B, Romeo V, Romanini ME, Luciano D, Zupi E, Arduini D. Automated three-dimensional coded contrast imaging hysterosalpingo-contrast sonography: feasibility in office tubal patency testing. Ultrasound Obstet Gynecol. 2013 Mar;41(3):328-35. doi: 10.1002/uog.11200.</citation>
    <PMID>22648792</PMID>
  </results_reference>
  <results_reference>
    <citation>He Y, Geng Q, Liu H, Han X. First experience using 4-dimensional hysterosalpingo-contrast sonography with SonoVue for assessing fallopian tube patency. J Ultrasound Med. 2013 Jul;32(7):1233-43. doi: 10.7863/ultra.32.7.1233.</citation>
    <PMID>23804346</PMID>
  </results_reference>
  <results_reference>
    <citation>Tur-Kaspa I. Fear no pain: uterine cavity and tubal patency assessment tests should be pain free. Ultrasound Obstet Gynecol. 2012 Mar;39(3):247-51. doi: 10.1002/uog.11128.</citation>
    <PMID>22535627</PMID>
  </results_reference>
  <results_reference>
    <citation>Marci R, Marcucci I, Marcucci AA, Pacini N, Salacone P, Sebastianelli A, Caponecchia L, Lo Monte G, Rago R. Hysterosalpingocontrast sonography (HyCoSy): evaluation of the pain perception, side effects and complications. BMC Med Imaging. 2013 Aug 23;13:28. doi: 10.1186/1471-2342-13-28.</citation>
    <PMID>23968513</PMID>
  </results_reference>
  <results_reference>
    <citation>Socolov D, Boian I, Boiculese L, Tamba B, Anghelache-Lupascu I, Socolov R. Comparison of the pain experienced by infertile women undergoing hysterosalpingo contrast sonography or radiographic hysterosalpingography. Int J Gynaecol Obstet. 2010 Dec;111(3):256-9. doi: 10.1016/j.ijgo.2010.07.018. Epub 2010 Sep 17.</citation>
    <PMID>20850745</PMID>
  </results_reference>
  <results_reference>
    <citation>Giugliano E, Cagnazzo E, Bazzan E, Patella A, Marci R. Hysterosalpingo-contrast sonography: is possible to quantify the therapeutic effect of a diagnostic test? Clin Exp Reprod Med. 2012 Dec;39(4):161-5. doi: 10.5653/cerm.2012.39.4.161. Epub 2012 Dec 31.</citation>
    <PMID>23346526</PMID>
  </results_reference>
  <results_reference>
    <citation>O'Flynn N. Assessment and treatment for people with fertility problems: NICE guideline. Br J Gen Pract. 2014 Jan;64(618):50-1. doi: 10.3399/bjgp14X676609.</citation>
    <PMID>24567574</PMID>
  </results_reference>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 4, 2015</study_first_submitted>
  <study_first_submitted_qc>July 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2015</study_first_posted>
  <last_update_submitted>July 21, 2015</last_update_submitted>
  <last_update_submitted_qc>July 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University First Hospital</investigator_affiliation>
    <investigator_full_name>Bai Wen-Pei</investigator_full_name>
    <investigator_title>Professor,Chief of Obstetrics and Gynecology Department</investigator_title>
  </responsible_party>
  <keyword>feasibility</keyword>
  <keyword>accuracy</keyword>
  <keyword>tolerability</keyword>
  <keyword>four dimensional hysterosalpingo-contrast sonography</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

